1. Home
  2. PRGO vs PGEN Comparison

PRGO vs PGEN Comparison

Compare PRGO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$10.78

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.30

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRGO
PGEN
Founded
1887
1998
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
PRGO
PGEN
Price
$10.78
$3.30
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$19.33
$7.67
AVG Volume (30 Days)
2.8M
4.7M
Earning Date
05-29-2026
01-01-0001
Dividend Yield
10.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$800,000.00
$230,981,000.00
Revenue This Year
$0.02
$342.78
Revenue Next Year
$1.36
$478.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.13
$1.11
52 Week High
$29.08
$5.47

Technical Indicators

Market Signals
Indicator
PRGO
PGEN
Relative Strength Index (RSI) 22.11 32.12
Support Level N/A $2.99
Resistance Level $15.08 $5.10
Average True Range (ATR) 0.60 0.32
MACD -0.41 -0.12
Stochastic Oscillator 2.84 3.34

Price Performance

Historical Comparison
PRGO
PGEN

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: